After half-billion dollars, nearly quarter century, Peninsula biotech lands its first FDA drug...

Published on 8 Oct 2021 on American City Business Journals

ChemoCentryx Inc.ended the longest leg of a 24-year, half-billion-dollar rollercoaster ride Friday,...

Read the rest of the article

Start tracking your investments with Statfolio

For those looking to find strong Medical stocks, it is prudent to search for companies in the gro...

Zacks via Yahoo Finance 6 Oct 2022

A month has gone by since the last earnings report for ChemoCentryx (CCXI). Shares have added abo...

Zacks via Yahoo Finance 7 Sep 2022

Amgen Inc.'s persistence and patience won out in a 29-month saga that landed it a Peninsula compa...

American City Business Journals 1 Sep 2022

Shares of Aerie Pharmaceuticals AERI have skyrocketed in the past three months, outpacing other m...

Zacks via Yahoo Finance 31 Aug 2022

Wednesday, August 31, 2022 The Zacks Research Daily presents the best research output of our anal...

Zacks via Yahoo Finance 31 Aug 2022

Amgen AMGN has a diverse and growing portfolio of medicines in large therapeutic categories that ...

Zacks via Yahoo Finance 30 Aug 2022

ETFS Biotech is back. For those who want to invest through exchange-traded funds, here are some c...

The Wall Street Journal 19 Aug 2022

After reaching an important support level, ChemoCentryx, Inc. (CCXI) could be a good stock pick f...

Zacks via Yahoo Finance 16 Aug 2022

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 16 Aug 2022

For Immediate Release Chicago, IL – August 12, 2022 – Zacks.com announces the list of stocks feat...

Zacks via Yahoo Finance 12 Aug 2022